# Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary

> **NCT00126269** · PHASE3 · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 192 (—)

## Conditions studied

- Carcinoma

## Interventions

- **DRUG:** cisplatin
- **DRUG:** gemcitabine

## Key facts

- **NCT ID:** NCT00126269
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 192 (—)
- **Last updated:** 2006-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00126269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00126269, "Trial Comparing Cisplatin With or Without Gemcitabine in Patients With Carcinoma of Unknown Primary". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT00126269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*